Overview of Dr. Donovan
Dr. Laura Donovan is a neurologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, NewYork-Presbyterian/Columbia University Irving Medical Center, and James J. Peters Veterans Affairs Medical Center. She received her medical degree from Emory University School of Medicine and has been in practice 5 years. She is one of 473 doctors at New York-Presbyterian Hospital and one of 209 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Neurology. She has more than 10 publications and over 200 citings.
Office
710 West 168th Street
New York, NY 10032- Is this information wrong?
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Neurology, 2013 - 2016
Brown UniversityResidency, Internal Medicine, 2012 - 2013
Emory University School of MedicineClass of 2012
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2016 - 2025
NJ State Medical License 2022 - 2025
CT State Medical License 2021 - 2024
RI State Medical License 2012 - 2013- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsHealth related quality of life trajectories after stereotactic radiosurgery for brain metastases: a systematic review.Adomas Bunevicius, Laura Donovan, Jason Sheehan> ;Journal of Neuro-Oncology. 2022 Sep 1
- Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas: A Retrospective Observational Study.Marissa Barbaro, Craig D. Blinderman, Fabio M. Iwamoto, Teri N. Kreisl, Mary Welch, Yazmin Odia, Laura E. Donovan, Adela E. Joanta-Gomez, Katharine A. Evans, Andrew B....> ;Neurology. 2021 Nov 18
- Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease.Laura E. Donovan, Eric B. Dammer, Duc M. Duong, John Hanfelt, Allan I. Levey, Nicholas T. Seyfried, James J. Lah> ;Alzheimer's Research & Therapy. 2021 May 18
- Join now to see all
Lectures
- Hyperprogressive disease in patients with recurrent high grade gliomas treated with immune checkpoint inhibitors or other therapies.2019 ASCO Annual Meeting - 6/1/2019
- A phase II, open label, single arm study of nivolumab for recurrent or progressive IDH mutant gliomas with prior exposure to alkylating agents.2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Press Mentions
Karen Killilea, 80, Dies; Turned Disability into TriumphDecember 18th, 2020- Researchers Report Promising New Therapy for Recurrent Pediatric Brain CancersMay 1st, 2020
CAR T Therapy Helps Treat Pediatric Brain TumorsApril 28th, 2020
Hospital Affiliations
New York-Presbyterian HospitalNew York, New York
NewYork-Presbyterian/Columbia University Irving Medical CenterNew York, New York
James J. Peters Veterans Affairs Medical CenterBronx, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
